Overview

CHS is a leading provider of comprehensive home infusion therapy and specialty infusion services to patients suffering from acute or chronic conditions. CHS delivers over 400,000 infusion pharmaceuticals, biopharmaceuticals, nutrients and related services each year to patients in the home through 35 infusion locations to 22 States, primarily in the eastern United States. CHS also provides over 350,000 nursing and therapy visits and 600,000 private duty nursing hours each year to patients in the home through 33 home nursing locations in 6 states. CHS currently provides customized local clinical care to over 15,000 patients through its branch network and has relationships with approximately 450 payors, including insurers, managed care organizations and government payors. For more information on CHS please visit the company website at (www.criticalhs.com). The information included on the CHS website is not incorporated by reference into this press release or in any filing with the Securities and Exchange Commission.

Press Releases | Stock Information | SEC Filings | WebCasts - Presentations